Title The American Psychiatric Association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia

Edition First edition Published Arlington, VA : American Psychiatric Association, [2016] ©2016

Click on the following:
Psychiatry Online

Copies

Description 1 online resource (vii, 210 pages) : illustrations Series American psychiatric association practice guideline American psychiatric association practice guidelines American Psychiatric Association practice guidelines. Contents Machine generated contents note: Overview of the Development Process -- Rating the Strength of Research Evidence and Recommendations -- Proper Use of Guidelines -- Guidelines and Implementation -- Guideline Statements -- Assessment of Behavioral/Psychological Symptoms of Dementia -- Development of a Comprehensive Treatment Plan -- Assessment of Benefits and Risks of Antipsychotic Treatment for the Patient -- Dosing, Duration, and Monitoring of Antipsychotic Treatment -- Use of Specific Antipsychotic Medications, Depending on Clinical Context -- Rationale -- Potential Benefits and Harms -- Benefits -- Harms -- Costs -- Balancing of Benefits and Harms in Rating the Strength of Recommendations -- Limitations of the Evidence in Assessing Benefits and Harms -- Implementation -- Assessment of Behavioral/Psychological Symptoms of Dementia -- Development of a Comprehensive Treatment Plan -- Assessment of Benefits and Risks of Antipsychotic Treatment for the Patient -- Dosing, Duration, and Monitoring of Antipsychotic Treatment -- Use of Specific Antipsychotic Medications, Depending on Clinical Context -- Quality Measurement Considerations -- Existing Measures of Relevance to Antipsychotic Use in Individuals With Dementia -- Variability in Practice That May Be Addressed by Quality Measures -- Potential Options for Measure Development -- Practical Barriers to Measure Development -- Additional Uses of Guideline Recommendations to Enhance Quality -- Guideline Development Process -- Management of Potential Conflicts of Interest -- Guideline Writing Group Composition -- Expert Opinion Data Collection -- Systematic Review Methodology -- Rating the Strength of Supporting Research Evidence -- Rating the Strength of Recommendations -- External Review -- Approval -- Glossary of Terms -- References -- Disclosures -- Individuals and Organizations That Submitted Comments -- Appendix A Review of Available Evidence -- Clinical Questions -- Review of Supporting Research Evidence -- 1A. Efficacy and Comparative Effectiveness of Second-Generation Antipsychotics for Overall BPSD -- 1B. Efficacy and Comparative Effectiveness of Second-Generation Antipsychotics for Treatment of Agitation -- 1C. Efficacy and Comparative Effectiveness of Second-Generation Antipsychotics for Treatment of Psychosis -- 2. Appropriate Dosage and Duration of Antipsychotic Treatment in Individuals With Alzheimer's Disease and Other Dementia Syndromes -- 3. Effects of Specific Patient Characteristics on Effectiveness and Harms of Antipsychotic Medications in Individuals With Dementia -- 4. Potential Adverse Effects and/or Complications Involved With Prescribing Second-Generation Antipsychotics to Patients -- Appendix B Expert Opinion Survey Data: Results -- Section I Questions About Appropriate Use -- Section II Duration of Treatment Summary The guideline offers clear, concise, and actionable recommendation statements to help clinicians to incorporate recommendations into clinical practice, with the goal of improving quality of care. Each recommendation is given a rating that reflects the level of confidence that potential benefits of an intervention outweigh potential harms Bibliography Includes bibliographical references Notes Online resource; title from resource electronic title page (PsychiatryOnline, viewed August 9, 2016) Subject Psychoses -- Chemotherapy. Antipsychotic drugs. Dementia -- Treatment Dementia -- drug therapy Dementia -- complications Antipsychotic Agents -- therapeutic use Psychomotor Agitation -- drug therapy Psychotic Disorders -- drug therapy Antipsychotic Agents Psychopharmacology. MEDICAL. Antipsychotic drugs Dementia -- Treatment Psychoses -- Chemotherapy Form Electronic book LC no. 2016015843 ISBN 9780890426807 9780890426784 0890426783 0890426805 9780890426807

Other Titles Practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia

  Permalink